Barclays’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,820	Closed	-$9K	–	4610
2023 Q1	$9K	Buy	35,820 +17,420	+95%	+$4.38K	﹤0.01%	4107
2022 Q4	$21K	Buy	18,400 +15,495	+533%	+$17.7K	﹤0.01%	4023
2022 Q3	$6K	Buy	+2,905	New	+$6K	﹤0.01%	4358